Apex Biotechnology Corp
TWSE:1733

Watchlist Manager
Apex Biotechnology Corp Logo
Apex Biotechnology Corp
TWSE:1733
Watchlist
Price: 29.6 TWD 0.17%
Market Cap: NT$3B

Wall Street
Price Targets

Price Targets Summary
Apex Biotechnology Corp

There are no price targets for Apex Biotechnology Corp.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Apex Biotechnology Corp Competitors:
Price Targets
LEG
Leggett & Platt Inc
28% Upside
ATC
Arctic Paper SA
41% Upside
ZIP
Ziprecruiter Inc
48% Upside
GWH
ESS Tech Inc
132% Upside

Revenue
Forecast

0% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
0% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Apex Biotechnology Corp's revenue is 0%.

Operating Income
Forecast

-11% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-11% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Apex Biotechnology Corp's operating income is -11%.

Net Income
Forecast

-10% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
-10% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 13 years the compound annual growth rate for Apex Biotechnology Corp's net income is -10%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Apex Biotechnology Corp's stock price target?
Not Available

Apex Biotechnology Corp doesn't have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett